causal
Benchling Should Not Be Judged as Veeva for R&D
When Benchling first appeared, the classic lens was to call it Veeva for R&D, but applying a Veeva template would have suffocated its potential, since its R&D focus and academic spinout users require a different motion than commercial pharma sales.
causalpending
Speaker
MilesEvidence Quote
“Benchling is on the R&D side, which is very different to being on the commercial side.”
Source
Miles Grimshaw - The DNA of Software Companies - [Invest Like the Best, EP.312]— Invest Like the BestCreated: 11/20/2026, 9:00:23 AM
Your notes
Loading notes...